ESSEX INVESTMENT MANAGEMENT CO LLC

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 201772 BOSTON, MA

Position in ARQT

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$3,391,085

-$711,424 QoQ

Shares Held

143,934

+1.9% QoQ

Ownership

0.115%

of shares outstanding

% of Portfolio

0.54%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 49.664429530201346.ToString("F0")% Shared 0.ToString("F0")% None 50.33557046979866.ToString("F0")%

Healthcare · as of Mar 31, 2026

ESSEX INVESTMENT MANAGEMENT CO LLC holds $60,210,603 across 12 Biotechnology names. ARQT ranks #8 (5.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc	58,460	$11,671,539
2	INSM	INSMED Inc	62,676	$10,248,779
3	MIRM	Mirum Pharmaceuticals, Inc.	108,338	$10,008,264
4	TVTX	Travere Therapeutics, Inc.	161,705	$4,804,255
5	SNDX	Syndax Pharmaceuticals Inc	198,985	$4,648,289
6	JAZZ	Jazz Pharmaceuticals plc	21,778	$4,117,130
7	AGIO	Agios Pharmaceuticals, Inc.	103,177	$3,490,477
8	ARQT	Arcutis Biotherapeutics, Inc. This page	143,934	$3,391,085

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,391,085	143,934	+1.9%	Shares	Sole	2026-05-11
2025-12-31	$4,102,509	141,271	-28.0%	Shares	Sole	2026-02-13
2025-09-30	$3,699,538	196,262	+3.6%	Shares	Sole	2025-11-06
2025-06-30	$2,656,944	189,511	-0.6%	Shares	Sole	2025-08-12
2025-03-31	$2,981,578	190,638	+33.5%	Shares	Sole	2025-05-07
2024-12-31	$1,989,524	142,823	-12.9%	Shares	Sole	2025-02-07
2024-09-30	$1,524,865	163,964	+0.2%	Shares	Sole	2024-10-10
2024-06-30	$1,521,117	163,561	—	Shares	Sole	2024-08-12
No filing history on record for this holder in this stock.